My two NIH cancer research grants were terminated today. One involving breast cancer prevention is an “outstanding investigator award” and had received a perfect score by reviewers. How does ending lifesaving cancer research make Americans healthier? Harvard Medical School @aacr

Dawn and I carry Joe Biden and his family in our hearts today.  He stood with me during some of the toughest times in our state, and we stand with him today. We pray for his strength and a swift recovery.

The NIH notified me yesterday that there is currently no policy that supports applying for a R00 that is associated with a terminated K99. So now, both the postdoc K99 (Harvard, $250k) and the R00 (non-Harvard institution TBD, $750) are BOTH effectively terminated.

NIH cuts are threatening life-changing research for families affected by SYNGAP1, a rare disorder that impacts brain development. At Johns Hopkins, scientists are closing in on a treatment. Parents are hoping for a future with fewer seizures, fewer medications, and more answers.

My heartiest congratulations to my first Postdoc mentor Dr. Kenneth Pienta The Johns Hopkins Brady Urological Institute on his portrait unveiling! He is an amazing Oncologist and Prostate Cancer researcher certainly worthy of this high honor!

Congrats to Dr.Jeremiah Wala, the first ASCO Dr.Felix Feng Endowed Young Investigator Awardee. Thanks to his friends and colleagues and Conquer Cancer, the ASCO Foundation for ensuring his legacy of creative science and a commitment to collaboration. Eric J. Small, MD, FASCO Eric Feng Nancy Lin, MD

By courageously sharing his prostate cancer diagnosis, Jay Harris is breaking the silence around men’s health. We applaud his strength and stand with him on his journey through treatment and recovery.

“From 2020 to 2024, universities contributed patents underpinning 50% of U.S. FDA-approved drugs. Even more stunningly, 87% of those academic breakthroughs came from American institutions.” statnews.com/2025/06/06/us-… via STAT

From the dismissal of dedicated scientists to proposed funding cuts, the cancer research community faces unprecedented challenges. AACR is working to defend science, preserve NIH investments in cancer research, and advocate for all patients. Learn more: brnw.ch/21wTgRJ

BREAKING: A federal judge says the termination of NIH grants for research on diversity-related topics by President Trump's administration was “void and illegal,” and accused the government of discriminating against racial minorities and LGBT people. nbcnews.com/science/scienc…

Happy Juneteenth! Let today also be a reminder to all that African-Americans were enslaved people in America far longer than free.

Michael Jung kicking off the PCF Science Coffey-Holden #ProstateCancer Academy discussing drug discovery His work to make enzalutamide has certainly made an impact!! 👏🏻👏🏻

Beautiful talk by Dr. Isla Garraway on CIN as biomarker for prostate cancer, development of algorithm for pathology detection of CIN by ⁦Beatrice Knudsen⁩, CIN targeting in clinical trials. #PCFAcademy ⁦PCF Science⁩

Ted Koppel interviews my Hopkins colleague Prof. Liz Jaffee, world expert in pancreatic cancer, about the devastating cuts and slow roll out of cancer research funding by the NIH. See this CBS Sunday morning show video here: youtube.com/watch?v=CLwcYQ…

Grant terminations have grabbed the headlines and have seen legal action, but even more damaging to the US research enterprise has been the massive decrease in research grants issued by federal agencies NIH: -57% in the number of awards and -63% in value compared to FY24

Not just one of the best scenes in Black TV History, but American Television history. Thanks for the memories Malcolm Jamal-Warner. This is how I’ll remember you. 🤩

Very proud of our Morgan State University summer student Ms. Jordan McCoy on her brilliant symposium studying macrophages in prostate cancer!

I cannot stress this enough: pairing a 4% funding line with the largest cut in NCI history will devastate the future of cancer research - and patients. We would be turning our backs on decades of progress.

This will not only impact the many scientific discoveries by researchers at US institutions but the patients who will benefit from these funded studies.

September is Prostate Cancer Awareness Month, an opportunity to highlight the second most common cancer in men - #prostatecancer. This month we want to remind men to: ✅ Learn about their risk factors ✅ Talk with their doctor ✅ #GetScreened #MensHealth